Shasun Pharmaceuticals Ltd (SHAS.NS)

SHAS.NS on National Stock Exchange of India

264.55INR
19 Dec 2014
Price Change (% chg)

Rs3.65 (+1.40%)
Prev Close
Rs260.90
Open
Rs263.50
Day's High
Rs268.40
Day's Low
Rs261.00
Volume
158,149
Avg. Vol
516,010
52-wk High
Rs291.70
52-wk Low
Rs68.80

SHAS.NS

Chart for SHAS.NS

About

Shasun Pharmaceuticals Limited (SPL) is an India-based company. The Company is primarily engaged in manufacturing of Active Pharmaceutical Ingredients (API), their intermediates and finished dosage. The Company is also into product development and provides contract research and manufacturing services. The Company operates in... (more)

Overall

Beta: 1.26
Market Cap (Mil.): Rs15,905.76
Shares Outstanding (Mil.): 60.12
Dividend: 1.00
Yield (%): 0.38

Financials

  SHAS.NS Industry Sector
P/E (TTM): 78.85 37.83 38.47
EPS (TTM): 3.36 -- --
ROI: 4.01 18.99 18.25
ROE: 5.94 19.75 19.13
Search Stocks

Strides Arcolab to buy Shasun Pharma for $200 mln in all-stock deal

MUMBAI - Strides Arcolab Ltd has agreed to buy smaller rival Shasun Pharmaceuticals Ltd in an all-stock deal, valued at about $200 million, to bolster its generic medicine and drug ingredient businesses.

29 Sep 2014

UPDATE 1-India's Strides Arcolab to buy Shasun Pharma for $200 mln in all-stock deal

* Deal valued at about $200 mln based on Friday closing price

29 Sep 2014

India's Strides Arcolab to buy Shasun Pharma in all-stock deal

MUMBAI, Sept 29 - Indian generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.

29 Sep 2014

UPDATE 3-Germany's Merck to buy Sigma-Aldrich for $17 bln to boost lab supplies operation

* Shares up 4 percent, outperforming sector index (Adds CEO comment, detail on pharma business)

22 Sep 2014

Earnings vs. Estimates

Search Stocks